(Q37510856)

20 August 2017

1 reference

title

Drug-induced liver injury: what was new in 2008? (English)

1 reference

20 August 2017

1 reference

Gordon Liss

1

1 reference

20 August 2017

James H Lewis

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

843-860

1 reference

Drug-related hepatotoxicity

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Inpatient admissions for drug-induced liver injury: results from a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Incidence of drug-induced liver injury in medical inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Causality assessment of drug-induced hepatotoxicity: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

The role of hepatitis E virus testing in drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Trastuzumab-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Sorafenib-induced liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Drug-induced liver injury: hepatotoxicity of quetiapine revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Pharmacogenomic biomarkers for prediction of severe adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Flucloxacillin-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

The current state of serum biomarkers of hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Genetic and molecular factors in drug-induced liver injury: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Human N-acetyltransferases and drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Cytochrome c: a non-invasive biomarker of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Cellular imaging predictions of clinical drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Predictive toxicogenomics in preclinical discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Idiosyncratic drug reactions: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Review article: The use of potentially hepatotoxic drugs in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

High prevalence of abnormal alanine and aspartate aminotransferases in a "worried-well" population in the United Kingdom: rationale for a liver screening program?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Assessment of drug-induced liver injury in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

A surveillance method for the early identification of idiosyncratic adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acetylcysteine for acetaminophen poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute liver failure due to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute liver failure: Summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acetaminophen overdose with altered acetaminophen pharmacokinetics and hepatotoxicity associated with premature cessation of intravenous N-acetylcysteine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Comparison of S-adenosyl-L-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Synergistic action of sodium selenite and N-acetylcysteine in acetaminophen-induced liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

I.V. acetaminophen pharmacokinetics in neonates after multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Estimated risk of hepatotoxicity after an acute acetaminophen overdose in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Does the patient history predict hepatotoxicity after acute paracetamol overdose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Part I: Liver function in oncology: biochemistry and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Part II: Liver function in oncology: towards safer chemotherapy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Management of hepatic complications in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir: review of cases from the FDA's Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatotoxicity of pyrazinamide: cohort and case-control analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Pharmacogenomics of anti-TB drugs-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute liver failure due to amoxicillin and amoxicillin/clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Troglitazone and liver injury: in search of answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Effect of thiazolidinediones on bile acid transport in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatotoxic slimming aids and other herbal hepatotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Spanish reports of hepatotoxicity associated with Herbalife® products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Herbal medicines for liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Safety of green tea extracts : a systematic review by the US Pharmacopeia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute liver failure induced by green tea extracts: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Causality assessment in hepatotoxicity by drugs and dietary supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Case-crossover study of hospitalization for acute hepatitis in Chinese herb users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatocellular toxicity of kava leaf and root extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Gamma-glutamyltranspeptidase-mediated degradation of diclofenac-S-acyl-glutathione in vitro and in vivo in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Nimesulide associated fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatotoxicity associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Acute hepatotoxicity associated with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Sulfamethoxazole/Trimethoprim induced liver failure: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

Minocycline hepatitis.

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Cholestatic liver injury associated with whey protein and creatine supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Portal vein thrombosis related to Cassia angustifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

A case of valerian-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatitis induced by Teucrium viscidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Herbal Does Not At All Mean Innocuous: The Sixth Case of Hepatotoxicity Associated With Morinda Citrifolia (Noni)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Extensive metabolism and hepatic accumulation of gemcitabine after multiple oral and intravenous administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Bicalutamide-associated fulminant hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Initially obscure hepatotoxicity attributed to sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Ondansetron-induced aminotransferase level elevation: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903018904

10.1517/17425250903018904

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference